CanProVar: A human cancer proteome variation database

Human Mutation

Volumn 31, Issue 3, 2010, Pages 219-228

  Li, Jing ^a   Duncan, Dexter T ^a   Zhang, Bing ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Application; Cancer; Database; Mutation; Proteomics; Web

Indexed keywords

PROTEOME;

AMINO ACID SEQUENCE; ARTICLE; COMPUTER INTERFACE; DATA BASE; GENE SEQUENCE; GENOME; HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN VARIANT; PUBLICATION; SAMPLING; SEQUENCE ANALYSIS;

ALGORITHMS; AMINO ACID SEQUENCE; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; GENETIC VARIATION; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PROTEOME; PROTEOMICS; TISSUE DISTRIBUTION; USER-COMPUTER INTERFACE;

EID: 77149126695     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21176     Document Type: Article

References (73)

1. Baldwin AS. 2001. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107:241-246.
2. Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, Flanagan A, Teague J, Futreal PA, Stratton MR, Wooster R. 2004. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91(2):355-358.
3. Baxter SW, Choong DY, Campbell IG. 2002. Microsomal epoxide hydrolase polymorphism and susceptibility to ovarian cancer. Cancer Lett 177:75-81.
4. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57:289-300.
5. Blume-Jensen P, Hunter T. 2001. Oncogenic kinase signalling. Nature 411:355-365.
6. Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O'Donovan C, Phan I, Pilbout S, Schneider M. 2003. The SWISSPROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res 31:365-370.
7. Boeckmann B, Blatter MC, Famiglietti L, Hinz U, Lane L, Roechert B, Bairoch A. 2005. Protein variety and functional diversity: Swiss-Prot annotation in its biological context. CR Biol 328:882-899.
8. Botstein D, Risch N. 2003. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 33(Suppl):228-237.
9. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES. 1999. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231-238.
10. Cederquist K, Emanuelsson M, Goransson I, Holinski-Feder E, Muller-Koch Y, Golovleva I, Gronberg H. 2004. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden. Int J Cancer 109:370-376.
11. Chanock S. 2001. Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease. Dis Markers 17:89-98.
12. Charames GS, Millar AL, Pal T, Narod S, Bapat B. 2000. Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium? Hum Genet 107:623-629.
13. Chasman D, Adams RM. 2001. Predicting the functional consequences of nonsynonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. J Mol Biol 307:683-706.
14. Chatr-aryamontri A, Ceol A, Palazzi LM, Nardelli G, Schneider MV, Castagnoli L, Cesareni G. 2007. MINT: the Molecular INTeraction database. Nucleic Acids Res 35(Database issue):D572-D574.
15. Chou TY, Chiu CH, Li LH, Hsiao CY, Tzen CY, Chang KT, Chen YM, Perng RP, Tsai SF, Tsai CM. 2005. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer. Clin Cancer Res 11:3750-3757.
16. Cimino JJ, Hayamizu TF, Bodenreider O, Davis B, Stafford GA, Ringwald M. 2009. The caBIG terminology review process. J Biomed Inform 42:571-580.
17. Clevenger CV. 2004. Roles and regulation of stat family transcription factors in human breast cancer. Am J Pathol 165:1449-1460.
18. Dantzer J, Moad C, Heiland R, Mooney S. 2005. MutDB services: interactive structural analysis of mutation data. Nucleic Acids Res 33(Web Server issue):W311-W314.
19. Di Nicolantonio F, Arena S, Gallicchio M, Zecchin D, Martini M, Flonta SE, Stella GM, Lamba S, Cancelliere C, Russo M, Geuna M, Appendino G, Fantozzi R, Medico E, Bardelli A. 2008. Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses. Proc Natl Acad Sci USA 105:20864-20869.
20. Dowell JE, Minna JD. 2005. Chasing mutations in the epidermal growth factor in lung cancer. N Engl J Med 352:830-832.
21. Engle LJ, Simpson CL, Landers JE. 2006. Using high-throughput SNP technologies to study cancer. Oncogene 25:1594-1601.
22. Feng LY, Ou ZL, Wu FY, Shen ZZ, Shao ZM. 2009. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin Cancer Res 15:2962-2970.
23. Fong JH, Geer LY, Panchenko AR, Bryant SH. 2007.Modeling the evolution of protein domain architectures using maximum parsimony. J Mol Biol 366:307-315.
24. Fredman D, Siegfried M, Yuan YP, Bork P, Lehvaslaiho H, Brookes AJ. 2002. HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources. Nucleic Acids Res 30:387-391.
25. Fredman D, Sawyer SL, Stromqvist L, Mottagui-Tabar S, Kidd KK, Wahlestedt C, Chanock SJ, Brookes AJ. 2006. Nonsynonymous SNPs: validation characteristics, derived allele frequency patterns, and suggestive evidence for natural selection. Hum Mutat 27:173-186.
26. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. 2004. A census of human cancer genes. Nat Rev Cancer 4:177-183.
27. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, and others. 2007. Patterns of somatic mutation in human cancer genomes. Nature 446:153-158.
28. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, Chakravarti A. 1999. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 22:239-247.
29. Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. 2005. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 33(Database issue):D514-D517.
30. Han A, Kang HJ, Cho Y, Lee S, Kim YJ, Gong S. 2006. SNP@Domain: a web resource of single nucleotide polymorphisms (SNPs) within protein domain structures and sequences. Nucleic Acids Res 34(Web Server issue):W642-W644.
31. Hartwell LH, Hopfield JJ, Leibler S, Murray AW. 1999. From molecular to modular cell biology. Nature 402(6761 Suppl):C47-C52.
32. Hengstler JG, Arand M, Herrero ME, Oesch F. 1998. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res 154:47-85.
33. Hoeijmakers JH. 2001. Genome maintenance mechanisms for preventing cancer. Nature 411:366-374.
34. Hondermarck H. 2003. Breast cancer: when proteomics challenges biological complexity. Mol Cell Proteomics 2:281-291.
35. Jegga AG, Gowrisankar S, Chen J, Aronow BJ. 2007. PolyDoms: a whole genome database for the identification of non-synonymous coding SNPs with the potential to impact disease. Nucleic Acids Res 35(Database issue): D700-D706.
36. Karchin R, Diekhans M, Kelly L, Thomas DJ, Pieper U, Eswar N, Haussler D, Sali A. 2005. LS-SNP: large-scale annotation of coding non-synonymous SNPs based on multiple information sources. Bioinformatics 21:2814-2820.
37. Kerrien S, Alam-Faruque Y, Aranda B, Bancarz I, Bridge A, Derow C, Dimmer E, Feuermann M, Friedrichsen A, Huntley R, Kohler C, Khadake J, Leroy C, Liban A, Lieftink C, Montecchi-Palazzi L, Orchard S, Risse J, Robbe K, Roechert B, Thorneycroft D, Zhang Y, Apweiler R, Hermjakob H. 2007. IntAct-open source resource for molecular interaction data. Nucleic Acids Res 35(Database issue):D561-D565.
38. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, Balakrishnan L, Marimuthu A, Banerjee S, Somanathan DS, Sebastian A, Rani S, Ray S, Harrys Kishore CJ, Kanth S, Ahmed M, Kashyap MK, Mohmood R, Ramachandra YL, Krishna V, Rahiman BA, Mohan S, Ranganathan P, Ramabadran S, Chaerkady R, Pandey A. 2009. Human Protein Reference Database-2009 update. Nucleic Acids Res 37(Database issue):D767-D772.
39. Koboldt DC, Miller RD, Kwok PY. 2006. Distribution of human SNPs and its effect on high-throughput genotyping. Hum Mutat 27:249-254.
40. Kolch W. 2000. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 351(Pt 2):289-305.
41. Lindstrom MS, Jin A, Deisenroth C, White Wolf G, Zhang Y. 2007. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation. Mol Cell Biol 27:1056-1068.
42. Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, de Bono B, Garapati P, Hemish J, Hermjakob H, Jassal B, Kanapin A, Lewis S, Mahajan S, May B, Schmidt E, Vastrik I, Wu G, Birhey E, Stein L, D'Eustachio P. 2009. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res 37(Database issue):D619-D622.
43. McIlwain CC, Townsend DM, Tew KD. 2006. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25:1639-1648.
44. Mewes HW, Dietmann S, Frishman D, Gregory R, Mannhaupt G, Mayer KF, Munsterkotter M, Ruepp A, Spannagl M, Stumpflen V, Rattei T. 2008. MIPS: analysis and annotation of genome information in 2007. Nucleic Acids Res 36(Database issue):D196-D201.
45. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. 1997. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787-1790.
46. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohan A, Verastegui E, Zlotnik A. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56.
47. O'Donovan C, Apweiler R, Bairoch A. 2001. The human proteomics initiative (HPI). Trends Biotechnol 19:178-181.
48. Olivier M, Petitjean A, Teague J, Forbes S, Dunnick JK, den Dunnen JT, Langerod A, Wilkinson JM, Vihinen M, Cotton RG, Hainaut P. 2009. Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: proposed guidelines for improving data collection, distribution, and integration. Hum Mutat 30:275-282.
49. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M. 2004. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500.
50. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M, Varmus H. 2004. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101:13306-13311.
51. Pincus D, Letunic I, Bork P, Lim WA. 2008. Evolution of the phospho-tyrosine signaling machinery in premetazoan lineages. Proc Natl Acad Sci USA 105:9680-9684.
52. Ramensky V, Bork P, Sunyaev S. 2002. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894-3900.
53. Reumers J, Schymkowitz J, Ferkinghoff-Borg J, Stricher F, Serrano L, Rousseau F. 2005. SNPeffect: a database mapping molecular phenotypic effects of human nonsynonymous coding SNPs. Nucleic Acids Res 33(Database issue):D527-D532.
54. Rhee H, Lee JS. 2009. MedRefSNP: a database of medically investigated SNPs. Hum Mutat 30:E460-E466.
55. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, Hu Y, Tan Z, Stokes M, Sullivan L, Mitchell J, Wetzel R, Macneill J, Ren JM, Yuan J, Bakalarski CE, Villen J, Kornhauser JM, Smith B, Li D, Zhou X, Gygi SP, Gu TL, Polakiewicz RD, Rush J, CombMJ. 2007. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131:1190-1203.
56. Schandorff S, Olsen JV, Bunkenborg J, Blagoev B, Zhang Y, Andersen JS, Mann M. 2007. A mass spectrometry-friendly database for cSNP identification. Nat Methods 4:465-466.
57. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhautts P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274.
58. Smedley D, Haider S, Ballester B, Holland R, London D, Thorisson G, Kasprzyk A. 2009. BioMart-biological queries made easy. BMC Genomics 10:22.
59. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN. 2003. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21:577-581.
60. Sunyaev S, Ramensky V, Koch I, Lathe 3rd W, Kondrashov AS, Bork P. 2001. Prediction of deleterious human alleles. Hum Mol Genet 10:591-597.
61. TCGA CGARN. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068.
62. Toubaji A, Achtar M, Provenzano M, Herrin VE, Behrens R, Hamilton M, Bernstein S, Venzon D, Gause B, Marincola F, and others. 2008. Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers. Cancer Immunol Immunother 57:1413-1420.
63. Trovo-Marqui AB, Tajara EH. 2006. Neurofibromin: a general outlook. Clin Genet 70:1-13.
64. Tsuruma T, Hata F, Furuhata T, Ohmura T, Katsuramaki T, Yamaguchi K, Kimura Y, Torigoe T, Sato N, Hirata K. 2005. Peptide-based vaccination for colorectal cancer. Expert Opin Biol Ther 5:799-807.
65. Uzun A, Leslin CM, Abyzov A, Ilyin V. 2007. Structure SNP (StSNP): a web server for mapping and modeling nsSNPs on protein structures with linkage to metabolic pathways. Nucleic Acids Res 35(Web Server issue):W384-W392.
66. von Eschenbach AC, Buetow K. 2007. Cancer Informatics Vision: caBIG. Cancer Inform 2:22-24.
67. Wang Z, Moult J. 2001. SNPs, protein structure, and disease. Hum Mutat 17: 263-270.
68. Weinstein IB. 2002. Cancer. Addiction to oncogenes-the Achilles heal of cancer. Science 297:63-64.
69. Wong OG, Nitkunan T, Oinuma I, Zhou C, Blanc V, Brown RS, Bott SR, Nariculam J, Box G, Munson P, Constantinou J, Feneley MR, Klocker H, Eccles SA, Negishi M, Freeman A, Masters JR,Williamson M. 2007. Plexin-B1 mutations in prostate cancer. Proc Natl Acad Sci USA 104:19040-19045.
70. Xenarios I, Salwinski L, Duan XJ, Higney P, Kim SM, Eisenberg D. 2002. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res 30:303-305.
71. Xi H, Park J, Ding G, Lee YH, Li Y. 2009. SysPIMP: the web-based systematical platform for identifying human disease-related mutated sequences from mass spectrometry. Nucleic Acids Res 37(Database issue):D913-D920.
72. Yip YL, Scheib H, Diemand AV, Gattiker A, Famiglietti LM, Gasteiger E, Bairoch A. 2004. The Swiss-Prot variant page and the ModSNP database: a resource for sequence and structure information on human protein variants. Hum Mutat 23:464-470.
73. Yokoyama A, Cleary ML. 2008. Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14:36-46.